nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—CRABP1—esophageal cancer	0.441	0.805	CbGaD
Tretinoin—CYP4A11—Cisplatin—esophageal cancer	0.131	0.736	CbGbCtD
Tretinoin—CYP2A6—esophageal cancer	0.107	0.195	CbGaD
Tretinoin—CYP2C9—Capecitabine—esophageal cancer	0.0191	0.107	CbGbCtD
Tretinoin—CYP2B6—Cisplatin—esophageal cancer	0.0182	0.102	CbGbCtD
Tretinoin—CYP2C9—Cisplatin—esophageal cancer	0.0096	0.054	CbGbCtD
Tretinoin—GPRC5A—digestive system—esophageal cancer	0.00317	0.0658	CbGeAlD
Tretinoin—GPRC5A—lung—esophageal cancer	0.00265	0.055	CbGeAlD
Tretinoin—CRABP1—neck—esophageal cancer	0.00229	0.0476	CbGeAlD
Tretinoin—RARRES1—bronchus—esophageal cancer	0.00207	0.0431	CbGeAlD
Tretinoin—Acitretin—CYP26A1—esophageal cancer	0.00193	0.37	CrCbGaD
Tretinoin—RARRES1—trachea—esophageal cancer	0.00186	0.0387	CbGeAlD
Tretinoin—RXRG—neck—esophageal cancer	0.00181	0.0376	CbGeAlD
Tretinoin—Alitretinoin—CRABP1—esophageal cancer	0.00178	0.34	CrCbGaD
Tretinoin—ALDH1A1—neck—esophageal cancer	0.00173	0.0359	CbGeAlD
Tretinoin—CRABP1—bronchus—esophageal cancer	0.00154	0.0319	CbGeAlD
Tretinoin—CRABP2—bronchus—esophageal cancer	0.00139	0.0288	CbGeAlD
Tretinoin—CRABP1—trachea—esophageal cancer	0.00138	0.0286	CbGeAlD
Tretinoin—CRABP2—smooth muscle tissue—esophageal cancer	0.00136	0.0282	CbGeAlD
Tretinoin—Vitamin A—CYP26A1—esophageal cancer	0.00135	0.259	CrCbGaD
Tretinoin—RARRES1—lung—esophageal cancer	0.00134	0.0278	CbGeAlD
Tretinoin—CRABP2—trachea—esophageal cancer	0.00125	0.0259	CbGeAlD
Tretinoin—RARB—bronchus—esophageal cancer	0.00124	0.0258	CbGeAlD
Tretinoin—CYP4A11—digestive system—esophageal cancer	0.00119	0.0246	CbGeAlD
Tretinoin—ALDH1A1—bronchus—esophageal cancer	0.00116	0.024	CbGeAlD
Tretinoin—NR0B1—lung—esophageal cancer	0.00115	0.0239	CbGeAlD
Tretinoin—ALDH1A1—smooth muscle tissue—esophageal cancer	0.00113	0.0235	CbGeAlD
Tretinoin—CRABP2—digestive system—esophageal cancer	0.00107	0.0223	CbGeAlD
Tretinoin—ALDH1A1—trachea—esophageal cancer	0.00104	0.0216	CbGeAlD
Tretinoin—ALDH1A2—lung—esophageal cancer	0.00103	0.0213	CbGeAlD
Tretinoin—CYP2C18—bronchus—esophageal cancer	0.00102	0.0211	CbGeAlD
Tretinoin—RARRES1—lymph node—esophageal cancer	0.000916	0.019	CbGeAlD
Tretinoin—CRABP2—lung—esophageal cancer	0.000896	0.0186	CbGeAlD
Tretinoin—ALDH1A1—digestive system—esophageal cancer	0.000894	0.0186	CbGeAlD
Tretinoin—RARB—lung—esophageal cancer	0.000801	0.0166	CbGeAlD
Tretinoin—CYP2C18—digestive system—esophageal cancer	0.000786	0.0163	CbGeAlD
Tretinoin—RARG—digestive system—esophageal cancer	0.000783	0.0162	CbGeAlD
Tretinoin—ALDH1A1—lung—esophageal cancer	0.000747	0.0155	CbGeAlD
Tretinoin—RXRB—lung—esophageal cancer	0.000736	0.0153	CbGeAlD
Tretinoin—ALDH1A2—lymph node—esophageal cancer	0.000702	0.0146	CbGeAlD
Tretinoin—RARG—lung—esophageal cancer	0.000654	0.0136	CbGeAlD
Tretinoin—RARA—lung—esophageal cancer	0.000615	0.0128	CbGeAlD
Tretinoin—RARB—lymph node—esophageal cancer	0.000548	0.0114	CbGeAlD
Tretinoin—ALDH1A1—lymph node—esophageal cancer	0.000511	0.0106	CbGeAlD
Tretinoin—RARG—lymph node—esophageal cancer	0.000447	0.00928	CbGeAlD
Tretinoin—CYP2A6—lung—esophageal cancer	0.000434	0.00901	CbGeAlD
Tretinoin—RARA—lymph node—esophageal cancer	0.00042	0.00873	CbGeAlD
Tretinoin—CYP1A1—epithelium—esophageal cancer	0.000354	0.00734	CbGeAlD
Tretinoin—CYP1A1—bronchus—esophageal cancer	0.000348	0.00723	CbGeAlD
Tretinoin—CYP2B6—bronchus—esophageal cancer	0.000339	0.00703	CbGeAlD
Tretinoin—CYP1A1—trachea—esophageal cancer	0.000313	0.00649	CbGeAlD
Tretinoin—CYP1A1—digestive system—esophageal cancer	0.000269	0.00559	CbGeAlD
Tretinoin—CYP3A5—digestive system—esophageal cancer	0.000263	0.00546	CbGeAlD
Tretinoin—CYP2B6—digestive system—esophageal cancer	0.000262	0.00543	CbGeAlD
Tretinoin—CYP2C9—digestive system—esophageal cancer	0.000259	0.00538	CbGeAlD
Tretinoin—CYP1A1—lung—esophageal cancer	0.000225	0.00467	CbGeAlD
Tretinoin—CYP3A5—lung—esophageal cancer	0.00022	0.00456	CbGeAlD
Tretinoin—CYP2B6—lung—esophageal cancer	0.000218	0.00453	CbGeAlD
Tretinoin—CYP3A4—digestive system—esophageal cancer	0.000198	0.0041	CbGeAlD
Tretinoin—Alitretinoin—ABCB1—esophageal cancer	0.000161	0.0307	CrCbGaD
Tretinoin—Mouth ulceration—Methotrexate—esophageal cancer	0.000154	0.00163	CcSEcCtD
Tretinoin—Bladder pain—Methotrexate—esophageal cancer	0.000154	0.00163	CcSEcCtD
Tretinoin—Urinary tract disorder—Cisplatin—esophageal cancer	0.000154	0.00163	CcSEcCtD
Tretinoin—CYP1A1—lymph node—esophageal cancer	0.000154	0.00319	CbGeAlD
Tretinoin—Urethral disorder—Cisplatin—esophageal cancer	0.000153	0.00162	CcSEcCtD
Tretinoin—Dry skin—Capecitabine—esophageal cancer	0.000152	0.00162	CcSEcCtD
Tretinoin—Pulmonary oedema—Methotrexate—esophageal cancer	0.000151	0.00161	CcSEcCtD
Tretinoin—Visual impairment—Cisplatin—esophageal cancer	0.00015	0.00159	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000149	0.00159	CcSEcCtD
Tretinoin—Nasopharyngitis—Capecitabine—esophageal cancer	0.000148	0.00158	CcSEcCtD
Tretinoin—Sepsis—Methotrexate—esophageal cancer	0.000148	0.00157	CcSEcCtD
Tretinoin—Gastritis—Capecitabine—esophageal cancer	0.000147	0.00156	CcSEcCtD
Tretinoin—Eye disorder—Cisplatin—esophageal cancer	0.000146	0.00155	CcSEcCtD
Tretinoin—Tinnitus—Cisplatin—esophageal cancer	0.000145	0.00154	CcSEcCtD
Tretinoin—Lymphadenopathy—Methotrexate—esophageal cancer	0.000145	0.00154	CcSEcCtD
Tretinoin—Flushing—Cisplatin—esophageal cancer	0.000145	0.00153	CcSEcCtD
Tretinoin—Abdominal distension—Capecitabine—esophageal cancer	0.000144	0.00153	CcSEcCtD
Tretinoin—Asthma—Capecitabine—esophageal cancer	0.000143	0.00152	CcSEcCtD
Tretinoin—Dysphagia—Capecitabine—esophageal cancer	0.000143	0.00152	CcSEcCtD
Tretinoin—Diabetes mellitus—Methotrexate—esophageal cancer	0.000142	0.00151	CcSEcCtD
Tretinoin—Bronchospasm—Capecitabine—esophageal cancer	0.000141	0.0015	CcSEcCtD
Tretinoin—Photosensitivity—Methotrexate—esophageal cancer	0.000141	0.00149	CcSEcCtD
Tretinoin—Sweating increased—Capecitabine—esophageal cancer	0.00014	0.00148	CcSEcCtD
Tretinoin—Arrhythmia—Cisplatin—esophageal cancer	0.000139	0.00148	CcSEcCtD
Tretinoin—Alopecia—Cisplatin—esophageal cancer	0.000138	0.00146	CcSEcCtD
Tretinoin—Abdominal discomfort—Capecitabine—esophageal cancer	0.000137	0.00146	CcSEcCtD
Tretinoin—Malnutrition—Cisplatin—esophageal cancer	0.000136	0.00144	CcSEcCtD
Tretinoin—Erythema—Cisplatin—esophageal cancer	0.000136	0.00144	CcSEcCtD
Tretinoin—Dysuria—Capecitabine—esophageal cancer	0.000134	0.00142	CcSEcCtD
Tretinoin—Neutropenia—Capecitabine—esophageal cancer	0.000134	0.00142	CcSEcCtD
Tretinoin—Renal failure acute—Methotrexate—esophageal cancer	0.000134	0.00142	CcSEcCtD
Tretinoin—Flatulence—Cisplatin—esophageal cancer	0.000134	0.00142	CcSEcCtD
Tretinoin—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.000133	0.00142	CcSEcCtD
Tretinoin—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000131	0.00139	CcSEcCtD
Tretinoin—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000131	0.00139	CcSEcCtD
Tretinoin—Weight increased—Capecitabine—esophageal cancer	0.000131	0.00139	CcSEcCtD
Tretinoin—Visual disturbance—Methotrexate—esophageal cancer	0.00013	0.00138	CcSEcCtD
Tretinoin—Weight decreased—Capecitabine—esophageal cancer	0.00013	0.00138	CcSEcCtD
Tretinoin—Pneumonia—Capecitabine—esophageal cancer	0.000129	0.00137	CcSEcCtD
Tretinoin—Infestation—Capecitabine—esophageal cancer	0.000128	0.00136	CcSEcCtD
Tretinoin—Infestation NOS—Capecitabine—esophageal cancer	0.000128	0.00136	CcSEcCtD
Tretinoin—Vision blurred—Cisplatin—esophageal cancer	0.000128	0.00136	CcSEcCtD
Tretinoin—Depression—Capecitabine—esophageal cancer	0.000128	0.00135	CcSEcCtD
Tretinoin—Tremor—Cisplatin—esophageal cancer	0.000127	0.00135	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000127	0.00135	CcSEcCtD
Tretinoin—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000126	0.00134	CcSEcCtD
Tretinoin—Lethargy—Methotrexate—esophageal cancer	0.000126	0.00134	CcSEcCtD
Tretinoin—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000126	0.00134	CcSEcCtD
Tretinoin—Ill-defined disorder—Cisplatin—esophageal cancer	0.000126	0.00134	CcSEcCtD
Tretinoin—Renal failure—Capecitabine—esophageal cancer	0.000126	0.00133	CcSEcCtD
Tretinoin—Myocardial infarction—Capecitabine—esophageal cancer	0.000125	0.00133	CcSEcCtD
Tretinoin—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000125	0.00133	CcSEcCtD
Tretinoin—Anaemia—Cisplatin—esophageal cancer	0.000125	0.00133	CcSEcCtD
Tretinoin—Stomatitis—Capecitabine—esophageal cancer	0.000125	0.00132	CcSEcCtD
Tretinoin—Conjunctivitis—Capecitabine—esophageal cancer	0.000124	0.00132	CcSEcCtD
Tretinoin—Urinary tract infection—Capecitabine—esophageal cancer	0.000124	0.00132	CcSEcCtD
Tretinoin—Osteoarthritis—Methotrexate—esophageal cancer	0.000124	0.00131	CcSEcCtD
Tretinoin—Malaise—Cisplatin—esophageal cancer	0.000122	0.0013	CcSEcCtD
Tretinoin—Haematuria—Capecitabine—esophageal cancer	0.000122	0.00129	CcSEcCtD
Tretinoin—Epistaxis—Capecitabine—esophageal cancer	0.000121	0.00128	CcSEcCtD
Tretinoin—Agranulocytosis—Capecitabine—esophageal cancer	0.000119	0.00127	CcSEcCtD
Tretinoin—Irritability—Methotrexate—esophageal cancer	0.000118	0.00125	CcSEcCtD
Tretinoin—Convulsion—Cisplatin—esophageal cancer	0.000117	0.00125	CcSEcCtD
Tretinoin—Mood swings—Methotrexate—esophageal cancer	0.000117	0.00124	CcSEcCtD
Tretinoin—Myalgia—Cisplatin—esophageal cancer	0.000115	0.00123	CcSEcCtD
Tretinoin—Haemoglobin—Capecitabine—esophageal cancer	0.000115	0.00123	CcSEcCtD
Tretinoin—Anxiety—Cisplatin—esophageal cancer	0.000115	0.00122	CcSEcCtD
Tretinoin—Haemorrhage—Capecitabine—esophageal cancer	0.000115	0.00122	CcSEcCtD
Tretinoin—Hepatitis—Capecitabine—esophageal cancer	0.000115	0.00122	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000115	0.00122	CcSEcCtD
Tretinoin—Hypoaesthesia—Capecitabine—esophageal cancer	0.000114	0.00121	CcSEcCtD
Tretinoin—Discomfort—Cisplatin—esophageal cancer	0.000114	0.00121	CcSEcCtD
Tretinoin—Pharyngitis—Capecitabine—esophageal cancer	0.000114	0.00121	CcSEcCtD
Tretinoin—Urinary tract disorder—Capecitabine—esophageal cancer	0.000113	0.0012	CcSEcCtD
Tretinoin—Oedema peripheral—Capecitabine—esophageal cancer	0.000113	0.0012	CcSEcCtD
Tretinoin—Urethral disorder—Capecitabine—esophageal cancer	0.000113	0.00119	CcSEcCtD
Tretinoin—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000111	0.00118	CcSEcCtD
Tretinoin—Oedema—Cisplatin—esophageal cancer	0.000111	0.00117	CcSEcCtD
Tretinoin—Anaphylactic shock—Cisplatin—esophageal cancer	0.000111	0.00117	CcSEcCtD
Tretinoin—Visual impairment—Capecitabine—esophageal cancer	0.000111	0.00117	CcSEcCtD
Tretinoin—Infection—Cisplatin—esophageal cancer	0.00011	0.00117	CcSEcCtD
Tretinoin—Erythema multiforme—Capecitabine—esophageal cancer	0.000109	0.00115	CcSEcCtD
Tretinoin—Nervous system disorder—Cisplatin—esophageal cancer	0.000109	0.00115	CcSEcCtD
Tretinoin—Thrombocytopenia—Cisplatin—esophageal cancer	0.000108	0.00115	CcSEcCtD
Tretinoin—Tachycardia—Cisplatin—esophageal cancer	0.000108	0.00115	CcSEcCtD
Tretinoin—Skin disorder—Cisplatin—esophageal cancer	0.000107	0.00114	CcSEcCtD
Tretinoin—Eye disorder—Capecitabine—esophageal cancer	0.000107	0.00114	CcSEcCtD
Tretinoin—Tinnitus—Capecitabine—esophageal cancer	0.000107	0.00114	CcSEcCtD
Tretinoin—Hyperhidrosis—Cisplatin—esophageal cancer	0.000107	0.00114	CcSEcCtD
Tretinoin—Asthma—Methotrexate—esophageal cancer	0.000107	0.00113	CcSEcCtD
Tretinoin—Flushing—Capecitabine—esophageal cancer	0.000107	0.00113	CcSEcCtD
Tretinoin—Anorexia—Cisplatin—esophageal cancer	0.000105	0.00112	CcSEcCtD
Tretinoin—Pancreatitis—Methotrexate—esophageal cancer	0.000105	0.00111	CcSEcCtD
Tretinoin—Angiopathy—Capecitabine—esophageal cancer	0.000104	0.00111	CcSEcCtD
Tretinoin—Hypotension—Cisplatin—esophageal cancer	0.000103	0.0011	CcSEcCtD
Tretinoin—Chills—Capecitabine—esophageal cancer	0.000103	0.00109	CcSEcCtD
Tretinoin—Arrhythmia—Capecitabine—esophageal cancer	0.000103	0.00109	CcSEcCtD
Tretinoin—Abdominal discomfort—Methotrexate—esophageal cancer	0.000102	0.00109	CcSEcCtD
Tretinoin—Alopecia—Capecitabine—esophageal cancer	0.000101	0.00108	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000101	0.00107	CcSEcCtD
Tretinoin—Mental disorder—Capecitabine—esophageal cancer	0.000101	0.00107	CcSEcCtD
Tretinoin—Erythema—Capecitabine—esophageal cancer	9.99e-05	0.00106	CcSEcCtD
Tretinoin—Malnutrition—Capecitabine—esophageal cancer	9.99e-05	0.00106	CcSEcCtD
Tretinoin—Neutropenia—Methotrexate—esophageal cancer	9.98e-05	0.00106	CcSEcCtD
Tretinoin—Dysuria—Methotrexate—esophageal cancer	9.98e-05	0.00106	CcSEcCtD
Tretinoin—Paraesthesia—Cisplatin—esophageal cancer	9.93e-05	0.00105	CcSEcCtD
Tretinoin—Upper respiratory tract infection—Methotrexate—esophageal cancer	9.92e-05	0.00105	CcSEcCtD
Tretinoin—Dyspnoea—Cisplatin—esophageal cancer	9.86e-05	0.00105	CcSEcCtD
Tretinoin—Flatulence—Capecitabine—esophageal cancer	9.85e-05	0.00105	CcSEcCtD
Tretinoin—Photosensitivity reaction—Methotrexate—esophageal cancer	9.75e-05	0.00103	CcSEcCtD
Tretinoin—Back pain—Capecitabine—esophageal cancer	9.67e-05	0.00103	CcSEcCtD
Tretinoin—Decreased appetite—Cisplatin—esophageal cancer	9.62e-05	0.00102	CcSEcCtD
Tretinoin—Pneumonia—Methotrexate—esophageal cancer	9.57e-05	0.00102	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Cisplatin—esophageal cancer	9.55e-05	0.00101	CcSEcCtD
Tretinoin—Infestation—Methotrexate—esophageal cancer	9.52e-05	0.00101	CcSEcCtD
Tretinoin—Infestation NOS—Methotrexate—esophageal cancer	9.52e-05	0.00101	CcSEcCtD
Tretinoin—Drowsiness—Methotrexate—esophageal cancer	9.52e-05	0.00101	CcSEcCtD
Tretinoin—Depression—Methotrexate—esophageal cancer	9.49e-05	0.00101	CcSEcCtD
Tretinoin—Pain—Cisplatin—esophageal cancer	9.46e-05	0.001	CcSEcCtD
Tretinoin—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	9.44e-05	0.001	CcSEcCtD
Tretinoin—Vision blurred—Capecitabine—esophageal cancer	9.42e-05	0.001	CcSEcCtD
Tretinoin—Tremor—Capecitabine—esophageal cancer	9.36e-05	0.000994	CcSEcCtD
Tretinoin—Renal failure—Methotrexate—esophageal cancer	9.36e-05	0.000994	CcSEcCtD
Tretinoin—Stomatitis—Methotrexate—esophageal cancer	9.28e-05	0.000985	CcSEcCtD
Tretinoin—Ill-defined disorder—Capecitabine—esophageal cancer	9.27e-05	0.000985	CcSEcCtD
Tretinoin—Conjunctivitis—Methotrexate—esophageal cancer	9.25e-05	0.000983	CcSEcCtD
Tretinoin—Anaemia—Capecitabine—esophageal cancer	9.24e-05	0.000981	CcSEcCtD
Tretinoin—Sweating—Methotrexate—esophageal cancer	9.13e-05	0.000969	CcSEcCtD
Tretinoin—Feeling abnormal—Cisplatin—esophageal cancer	9.12e-05	0.000968	CcSEcCtD
Tretinoin—Haematuria—Methotrexate—esophageal cancer	9.08e-05	0.000964	CcSEcCtD
Tretinoin—Malaise—Capecitabine—esophageal cancer	9.01e-05	0.000957	CcSEcCtD
Tretinoin—Epistaxis—Methotrexate—esophageal cancer	8.98e-05	0.000953	CcSEcCtD
Tretinoin—Syncope—Capecitabine—esophageal cancer	8.96e-05	0.000952	CcSEcCtD
Tretinoin—Agranulocytosis—Methotrexate—esophageal cancer	8.88e-05	0.000943	CcSEcCtD
Tretinoin—Palpitations—Capecitabine—esophageal cancer	8.83e-05	0.000938	CcSEcCtD
Tretinoin—Loss of consciousness—Capecitabine—esophageal cancer	8.78e-05	0.000933	CcSEcCtD
Tretinoin—Body temperature increased—Cisplatin—esophageal cancer	8.75e-05	0.000929	CcSEcCtD
Tretinoin—Cough—Capecitabine—esophageal cancer	8.72e-05	0.000926	CcSEcCtD
Tretinoin—Hypertension—Capecitabine—esophageal cancer	8.63e-05	0.000916	CcSEcCtD
Tretinoin—Haemoglobin—Methotrexate—esophageal cancer	8.59e-05	0.000912	CcSEcCtD
Tretinoin—Haemorrhage—Methotrexate—esophageal cancer	8.55e-05	0.000907	CcSEcCtD
Tretinoin—Hepatitis—Methotrexate—esophageal cancer	8.55e-05	0.000907	CcSEcCtD
Tretinoin—Chest pain—Capecitabine—esophageal cancer	8.51e-05	0.000903	CcSEcCtD
Tretinoin—Myalgia—Capecitabine—esophageal cancer	8.51e-05	0.000903	CcSEcCtD
Tretinoin—Arthralgia—Capecitabine—esophageal cancer	8.51e-05	0.000903	CcSEcCtD
Tretinoin—Pharyngitis—Methotrexate—esophageal cancer	8.48e-05	0.000901	CcSEcCtD
Tretinoin—Anxiety—Capecitabine—esophageal cancer	8.48e-05	0.0009	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	8.45e-05	0.000897	CcSEcCtD
Tretinoin—Urinary tract disorder—Methotrexate—esophageal cancer	8.44e-05	0.000896	CcSEcCtD
Tretinoin—Discomfort—Capecitabine—esophageal cancer	8.41e-05	0.000893	CcSEcCtD
Tretinoin—Urethral disorder—Methotrexate—esophageal cancer	8.38e-05	0.00089	CcSEcCtD
Tretinoin—Dry mouth—Capecitabine—esophageal cancer	8.32e-05	0.000884	CcSEcCtD
Tretinoin—Visual impairment—Methotrexate—esophageal cancer	8.24e-05	0.000874	CcSEcCtD
Tretinoin—Confusional state—Capecitabine—esophageal cancer	8.22e-05	0.000873	CcSEcCtD
Tretinoin—Oedema—Capecitabine—esophageal cancer	8.16e-05	0.000866	CcSEcCtD
Tretinoin—Hypersensitivity—Cisplatin—esophageal cancer	8.15e-05	0.000866	CcSEcCtD
Tretinoin—Infection—Capecitabine—esophageal cancer	8.1e-05	0.00086	CcSEcCtD
Tretinoin—Erythema multiforme—Methotrexate—esophageal cancer	8.08e-05	0.000858	CcSEcCtD
Tretinoin—Shock—Capecitabine—esophageal cancer	8.02e-05	0.000852	CcSEcCtD
Tretinoin—Nervous system disorder—Capecitabine—esophageal cancer	8e-05	0.000849	CcSEcCtD
Tretinoin—Eye disorder—Methotrexate—esophageal cancer	7.99e-05	0.000848	CcSEcCtD
Tretinoin—Thrombocytopenia—Capecitabine—esophageal cancer	7.99e-05	0.000848	CcSEcCtD
Tretinoin—Tinnitus—Methotrexate—esophageal cancer	7.97e-05	0.000846	CcSEcCtD
Tretinoin—Tachycardia—Capecitabine—esophageal cancer	7.96e-05	0.000845	CcSEcCtD
Tretinoin—Asthenia—Cisplatin—esophageal cancer	7.94e-05	0.000843	CcSEcCtD
Tretinoin—Skin disorder—Capecitabine—esophageal cancer	7.92e-05	0.000841	CcSEcCtD
Tretinoin—Hyperhidrosis—Capecitabine—esophageal cancer	7.88e-05	0.000837	CcSEcCtD
Tretinoin—Anorexia—Capecitabine—esophageal cancer	7.77e-05	0.000826	CcSEcCtD
Tretinoin—Angiopathy—Methotrexate—esophageal cancer	7.75e-05	0.000823	CcSEcCtD
Tretinoin—Chills—Methotrexate—esophageal cancer	7.67e-05	0.000814	CcSEcCtD
Tretinoin—Hypotension—Capecitabine—esophageal cancer	7.62e-05	0.000809	CcSEcCtD
Tretinoin—Diarrhoea—Cisplatin—esophageal cancer	7.57e-05	0.000804	CcSEcCtD
Tretinoin—Alopecia—Methotrexate—esophageal cancer	7.55e-05	0.000802	CcSEcCtD
Tretinoin—Mental disorder—Methotrexate—esophageal cancer	7.49e-05	0.000795	CcSEcCtD
Tretinoin—Malnutrition—Methotrexate—esophageal cancer	7.44e-05	0.00079	CcSEcCtD
Tretinoin—Erythema—Methotrexate—esophageal cancer	7.44e-05	0.00079	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	7.43e-05	0.000789	CcSEcCtD
Tretinoin—Insomnia—Capecitabine—esophageal cancer	7.38e-05	0.000783	CcSEcCtD
Tretinoin—Paraesthesia—Capecitabine—esophageal cancer	7.32e-05	0.000778	CcSEcCtD
Tretinoin—Dyspnoea—Capecitabine—esophageal cancer	7.27e-05	0.000772	CcSEcCtD
Tretinoin—Back pain—Methotrexate—esophageal cancer	7.2e-05	0.000764	CcSEcCtD
Tretinoin—Dyspepsia—Capecitabine—esophageal cancer	7.18e-05	0.000762	CcSEcCtD
Tretinoin—Decreased appetite—Capecitabine—esophageal cancer	7.09e-05	0.000753	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Capecitabine—esophageal cancer	7.04e-05	0.000748	CcSEcCtD
Tretinoin—Vomiting—Cisplatin—esophageal cancer	7.03e-05	0.000747	CcSEcCtD
Tretinoin—Fatigue—Capecitabine—esophageal cancer	7.03e-05	0.000747	CcSEcCtD
Tretinoin—Vision blurred—Methotrexate—esophageal cancer	7.01e-05	0.000744	CcSEcCtD
Tretinoin—Rash—Cisplatin—esophageal cancer	6.98e-05	0.000741	CcSEcCtD
Tretinoin—Constipation—Capecitabine—esophageal cancer	6.97e-05	0.000741	CcSEcCtD
Tretinoin—Pain—Capecitabine—esophageal cancer	6.97e-05	0.000741	CcSEcCtD
Tretinoin—Dermatitis—Cisplatin—esophageal cancer	6.97e-05	0.00074	CcSEcCtD
Tretinoin—Ill-defined disorder—Methotrexate—esophageal cancer	6.9e-05	0.000733	CcSEcCtD
Tretinoin—Anaemia—Methotrexate—esophageal cancer	6.88e-05	0.00073	CcSEcCtD
Tretinoin—Feeling abnormal—Capecitabine—esophageal cancer	6.72e-05	0.000714	CcSEcCtD
Tretinoin—Malaise—Methotrexate—esophageal cancer	6.71e-05	0.000712	CcSEcCtD
Tretinoin—Gastrointestinal pain—Capecitabine—esophageal cancer	6.67e-05	0.000708	CcSEcCtD
Tretinoin—Nausea—Cisplatin—esophageal cancer	6.57e-05	0.000698	CcSEcCtD
Tretinoin—Cough—Methotrexate—esophageal cancer	6.49e-05	0.000689	CcSEcCtD
Tretinoin—Urticaria—Capecitabine—esophageal cancer	6.48e-05	0.000688	CcSEcCtD
Tretinoin—Abdominal pain—Capecitabine—esophageal cancer	6.45e-05	0.000685	CcSEcCtD
Tretinoin—Body temperature increased—Capecitabine—esophageal cancer	6.45e-05	0.000685	CcSEcCtD
Tretinoin—Convulsion—Methotrexate—esophageal cancer	6.45e-05	0.000684	CcSEcCtD
Tretinoin—Arthralgia—Methotrexate—esophageal cancer	6.33e-05	0.000673	CcSEcCtD
Tretinoin—Chest pain—Methotrexate—esophageal cancer	6.33e-05	0.000673	CcSEcCtD
Tretinoin—Myalgia—Methotrexate—esophageal cancer	6.33e-05	0.000673	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	6.29e-05	0.000668	CcSEcCtD
Tretinoin—Discomfort—Methotrexate—esophageal cancer	6.26e-05	0.000664	CcSEcCtD
Tretinoin—Confusional state—Methotrexate—esophageal cancer	6.12e-05	0.00065	CcSEcCtD
Tretinoin—Anaphylactic shock—Methotrexate—esophageal cancer	6.07e-05	0.000645	CcSEcCtD
Tretinoin—Infection—Methotrexate—esophageal cancer	6.03e-05	0.00064	CcSEcCtD
Tretinoin—Hypersensitivity—Capecitabine—esophageal cancer	6.01e-05	0.000638	CcSEcCtD
Tretinoin—Nervous system disorder—Methotrexate—esophageal cancer	5.95e-05	0.000632	CcSEcCtD
Tretinoin—Thrombocytopenia—Methotrexate—esophageal cancer	5.94e-05	0.000631	CcSEcCtD
Tretinoin—Skin disorder—Methotrexate—esophageal cancer	5.9e-05	0.000626	CcSEcCtD
Tretinoin—Hyperhidrosis—Methotrexate—esophageal cancer	5.87e-05	0.000623	CcSEcCtD
Tretinoin—Asthenia—Capecitabine—esophageal cancer	5.85e-05	0.000621	CcSEcCtD
Tretinoin—Anorexia—Methotrexate—esophageal cancer	5.79e-05	0.000615	CcSEcCtD
Tretinoin—Pruritus—Capecitabine—esophageal cancer	5.77e-05	0.000613	CcSEcCtD
Tretinoin—Hypotension—Methotrexate—esophageal cancer	5.67e-05	0.000602	CcSEcCtD
Tretinoin—Diarrhoea—Capecitabine—esophageal cancer	5.58e-05	0.000593	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	5.53e-05	0.000587	CcSEcCtD
Tretinoin—Insomnia—Methotrexate—esophageal cancer	5.49e-05	0.000583	CcSEcCtD
Tretinoin—Paraesthesia—Methotrexate—esophageal cancer	5.45e-05	0.000579	CcSEcCtD
Tretinoin—Dyspnoea—Methotrexate—esophageal cancer	5.41e-05	0.000575	CcSEcCtD
Tretinoin—Somnolence—Methotrexate—esophageal cancer	5.4e-05	0.000573	CcSEcCtD
Tretinoin—Dizziness—Capecitabine—esophageal cancer	5.39e-05	0.000573	CcSEcCtD
Tretinoin—Dyspepsia—Methotrexate—esophageal cancer	5.34e-05	0.000568	CcSEcCtD
Tretinoin—Decreased appetite—Methotrexate—esophageal cancer	5.28e-05	0.00056	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Methotrexate—esophageal cancer	5.24e-05	0.000557	CcSEcCtD
Tretinoin—Fatigue—Methotrexate—esophageal cancer	5.23e-05	0.000556	CcSEcCtD
Tretinoin—Pain—Methotrexate—esophageal cancer	5.19e-05	0.000551	CcSEcCtD
Tretinoin—Vomiting—Capecitabine—esophageal cancer	5.19e-05	0.000551	CcSEcCtD
Tretinoin—Rash—Capecitabine—esophageal cancer	5.14e-05	0.000546	CcSEcCtD
Tretinoin—Dermatitis—Capecitabine—esophageal cancer	5.14e-05	0.000546	CcSEcCtD
Tretinoin—Headache—Capecitabine—esophageal cancer	5.11e-05	0.000543	CcSEcCtD
Tretinoin—Feeling abnormal—Methotrexate—esophageal cancer	5e-05	0.000531	CcSEcCtD
Tretinoin—Gastrointestinal pain—Methotrexate—esophageal cancer	4.96e-05	0.000527	CcSEcCtD
Tretinoin—Nausea—Capecitabine—esophageal cancer	4.84e-05	0.000514	CcSEcCtD
Tretinoin—Urticaria—Methotrexate—esophageal cancer	4.82e-05	0.000512	CcSEcCtD
Tretinoin—Body temperature increased—Methotrexate—esophageal cancer	4.8e-05	0.00051	CcSEcCtD
Tretinoin—Abdominal pain—Methotrexate—esophageal cancer	4.8e-05	0.00051	CcSEcCtD
Tretinoin—Hypersensitivity—Methotrexate—esophageal cancer	4.47e-05	0.000475	CcSEcCtD
Tretinoin—Asthenia—Methotrexate—esophageal cancer	4.36e-05	0.000463	CcSEcCtD
Tretinoin—Pruritus—Methotrexate—esophageal cancer	4.3e-05	0.000456	CcSEcCtD
Tretinoin—Diarrhoea—Methotrexate—esophageal cancer	4.15e-05	0.000441	CcSEcCtD
Tretinoin—Dizziness—Methotrexate—esophageal cancer	4.01e-05	0.000426	CcSEcCtD
Tretinoin—Vomiting—Methotrexate—esophageal cancer	3.86e-05	0.00041	CcSEcCtD
Tretinoin—Rash—Methotrexate—esophageal cancer	3.83e-05	0.000406	CcSEcCtD
Tretinoin—Dermatitis—Methotrexate—esophageal cancer	3.82e-05	0.000406	CcSEcCtD
Tretinoin—Headache—Methotrexate—esophageal cancer	3.8e-05	0.000404	CcSEcCtD
Tretinoin—Nausea—Methotrexate—esophageal cancer	3.61e-05	0.000383	CcSEcCtD
Tretinoin—CYP2B6—Metabolism—TYMP—esophageal cancer	6.8e-06	5.36e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	6.79e-06	5.35e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ALDH2—esophageal cancer	6.78e-06	5.34e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—TYMP—esophageal cancer	6.64e-06	5.24e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GNG7—esophageal cancer	6.63e-06	5.23e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—HMOX1—esophageal cancer	6.63e-06	5.23e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP26A1—esophageal cancer	6.61e-06	5.21e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—EP300—esophageal cancer	6.61e-06	5.21e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CYP19A1—esophageal cancer	6.59e-06	5.2e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CA1—esophageal cancer	6.57e-06	5.18e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC10A2—esophageal cancer	6.57e-06	5.18e-05	CbGpPWpGaD
Tretinoin—RARG—Gene Expression—MYC—esophageal cancer	6.57e-06	5.18e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ADH1B—esophageal cancer	6.57e-06	5.18e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP26A1—esophageal cancer	6.46e-06	5.1e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GSTT1—esophageal cancer	6.44e-06	5.08e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ALOX15—esophageal cancer	6.44e-06	5.08e-05	CbGpPWpGaD
Tretinoin—CRABP1—Metabolism—PIK3CA—esophageal cancer	6.42e-06	5.06e-05	CbGpPWpGaD
Tretinoin—ALDH1A1—Metabolism—PIK3CA—esophageal cancer	6.42e-06	5.06e-05	CbGpPWpGaD
Tretinoin—CRABP2—Metabolism—PIK3CA—esophageal cancer	6.42e-06	5.06e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP2A6—esophageal cancer	6.37e-06	5.02e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ABCB1—esophageal cancer	6.36e-06	5.02e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ALOX15—esophageal cancer	6.3e-06	4.97e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—TYMP—esophageal cancer	6.28e-06	4.95e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ALDH2—esophageal cancer	6.21e-06	4.9e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTO1—esophageal cancer	6.15e-06	4.85e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—TPI1—esophageal cancer	6.15e-06	4.85e-05	CbGpPWpGaD
Tretinoin—RXRA—Generic Transcription Pathway—MYC—esophageal cancer	6.11e-06	4.82e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP26A1—esophageal cancer	6.11e-06	4.81e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ENO1—esophageal cancer	6.04e-06	4.76e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS1—esophageal cancer	6.04e-06	4.76e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ADH1B—esophageal cancer	6.02e-06	4.75e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—HMOX1—esophageal cancer	6.01e-06	4.74e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CA2—esophageal cancer	6.01e-06	4.74e-05	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—MYC—esophageal cancer	6.01e-06	4.74e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTO1—esophageal cancer	6.01e-06	4.74e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—TPI1—esophageal cancer	6.01e-06	4.74e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PSME1—esophageal cancer	5.95e-06	4.69e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PSME2—esophageal cancer	5.95e-06	4.69e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ALOX15—esophageal cancer	5.95e-06	4.69e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GSTT1—esophageal cancer	5.91e-06	4.66e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	5.9e-06	4.65e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ALDOB—esophageal cancer	5.89e-06	4.65e-05	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—MYC—esophageal cancer	5.89e-06	4.65e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	5.88e-06	4.63e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ABCB1—esophageal cancer	5.77e-06	4.55e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ALDOB—esophageal cancer	5.76e-06	4.54e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—TYMP—esophageal cancer	5.75e-06	4.54e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTO1—esophageal cancer	5.68e-06	4.48e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—TPI1—esophageal cancer	5.68e-06	4.48e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GAPDH—esophageal cancer	5.67e-06	4.47e-05	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—MYC—esophageal cancer	5.65e-06	4.45e-05	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—MYC—esophageal cancer	5.65e-06	4.45e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—EGFR—esophageal cancer	5.63e-06	4.44e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CRABP1—esophageal cancer	5.62e-06	4.43e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP26A1—esophageal cancer	5.6e-06	4.41e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ADH7—esophageal cancer	5.59e-06	4.41e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PLCE1—esophageal cancer	5.59e-06	4.41e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GAPDH—esophageal cancer	5.54e-06	4.37e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ENO1—esophageal cancer	5.54e-06	4.36e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS1—esophageal cancer	5.54e-06	4.36e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	5.52e-06	4.36e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.5e-06	4.34e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CRABP1—esophageal cancer	5.5e-06	4.33e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—NOTCH1—esophageal cancer	5.47e-06	4.31e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALOX15—esophageal cancer	5.45e-06	4.3e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PSME2—esophageal cancer	5.45e-06	4.3e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PSME1—esophageal cancer	5.45e-06	4.3e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ALDOB—esophageal cancer	5.44e-06	4.29e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GNG7—esophageal cancer	5.35e-06	4.22e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GAPDH—esophageal cancer	5.24e-06	4.13e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GNG7—esophageal cancer	5.23e-06	4.12e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTO1—esophageal cancer	5.2e-06	4.1e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—TPI1—esophageal cancer	5.2e-06	4.1e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CRABP1—esophageal cancer	5.19e-06	4.09e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP1B1—esophageal cancer	5.13e-06	4.05e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC52A3—esophageal cancer	5.1e-06	4.02e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—BLVRB—esophageal cancer	5.1e-06	4.02e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ALDH2—esophageal cancer	5.01e-06	3.95e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALDOB—esophageal cancer	4.99e-06	3.93e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—CREBBP—esophageal cancer	4.96e-06	3.91e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GNG7—esophageal cancer	4.94e-06	3.89e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ADH1B—esophageal cancer	4.9e-06	3.86e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ALDH2—esophageal cancer	4.9e-06	3.86e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—CREBBP—esophageal cancer	4.86e-06	3.83e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CYP19A1—esophageal cancer	4.83e-06	3.81e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GAPDH—esophageal cancer	4.8e-06	3.79e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTT1—esophageal cancer	4.77e-06	3.76e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CRABP1—esophageal cancer	4.76e-06	3.75e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP2A6—esophageal cancer	4.71e-06	3.71e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP1B1—esophageal cancer	4.71e-06	3.71e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—TYMP—esophageal cancer	4.68e-06	3.69e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTT1—esophageal cancer	4.66e-06	3.67e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ALDH2—esophageal cancer	4.63e-06	3.65e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP2A6—esophageal cancer	4.6e-06	3.63e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP26A1—esophageal cancer	4.56e-06	3.59e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GNG7—esophageal cancer	4.53e-06	3.57e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ENO1—esophageal cancer	4.47e-06	3.52e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS1—esophageal cancer	4.47e-06	3.52e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALOX15—esophageal cancer	4.44e-06	3.5e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CYP19A1—esophageal cancer	4.43e-06	3.49e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—HMOX1—esophageal cancer	4.41e-06	3.47e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTT1—esophageal cancer	4.4e-06	3.47e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PSME2—esophageal cancer	4.4e-06	3.47e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PSME1—esophageal cancer	4.4e-06	3.47e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ENO1—esophageal cancer	4.37e-06	3.44e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS1—esophageal cancer	4.37e-06	3.44e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.36e-06	3.44e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—NOS3—esophageal cancer	4.35e-06	3.43e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP2A6—esophageal cancer	4.35e-06	3.43e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CA1—esophageal cancer	4.33e-06	3.42e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC10A2—esophageal cancer	4.33e-06	3.42e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.33e-06	3.42e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PSME1—esophageal cancer	4.3e-06	3.39e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PSME2—esophageal cancer	4.3e-06	3.39e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CREBBP—esophageal cancer	4.25e-06	3.35e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALDH2—esophageal cancer	4.24e-06	3.35e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTO1—esophageal cancer	4.24e-06	3.34e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—TPI1—esophageal cancer	4.24e-06	3.34e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ABCB1—esophageal cancer	4.23e-06	3.33e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ENO1—esophageal cancer	4.12e-06	3.25e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS1—esophageal cancer	4.12e-06	3.25e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PSME1—esophageal cancer	4.06e-06	3.2e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PSME2—esophageal cancer	4.06e-06	3.2e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALDOB—esophageal cancer	4.06e-06	3.2e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—HMOX1—esophageal cancer	4.04e-06	3.18e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTT1—esophageal cancer	4.04e-06	3.18e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP2A6—esophageal cancer	3.99e-06	3.14e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTGS2—esophageal cancer	3.98e-06	3.14e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.97e-06	3.13e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CA2—esophageal cancer	3.96e-06	3.13e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GAPDH—esophageal cancer	3.91e-06	3.08e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ABCB1—esophageal cancer	3.88e-06	3.06e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CRABP1—esophageal cancer	3.87e-06	3.05e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CREBBP—esophageal cancer	3.86e-06	3.04e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—NOS3—esophageal cancer	3.81e-06	3e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP1B1—esophageal cancer	3.8e-06	2.99e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ENO1—esophageal cancer	3.78e-06	2.98e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS1—esophageal cancer	3.78e-06	2.98e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PSME2—esophageal cancer	3.73e-06	2.94e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PSME1—esophageal cancer	3.73e-06	2.94e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP1B1—esophageal cancer	3.71e-06	2.93e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PLCE1—esophageal cancer	3.69e-06	2.91e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ADH7—esophageal cancer	3.69e-06	2.91e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GNG7—esophageal cancer	3.68e-06	2.91e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP19A1—esophageal cancer	3.57e-06	2.82e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.55e-06	2.8e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP1B1—esophageal cancer	3.51e-06	2.77e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP19A1—esophageal cancer	3.49e-06	2.75e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTGS2—esophageal cancer	3.48e-06	2.74e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—NOS3—esophageal cancer	3.45e-06	2.72e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALDH2—esophageal cancer	3.45e-06	2.72e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—EP300—esophageal cancer	3.31e-06	2.61e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP19A1—esophageal cancer	3.3e-06	2.6e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTT1—esophageal cancer	3.28e-06	2.59e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—HMOX1—esophageal cancer	3.26e-06	2.57e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.25e-06	2.57e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP2A6—esophageal cancer	3.25e-06	2.56e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.23e-06	2.55e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ADH1B—esophageal cancer	3.23e-06	2.55e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP1B1—esophageal cancer	3.21e-06	2.54e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—HMOX1—esophageal cancer	3.18e-06	2.51e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTGS2—esophageal cancer	3.16e-06	2.49e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ABCB1—esophageal cancer	3.13e-06	2.47e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TYMP—esophageal cancer	3.09e-06	2.44e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ENO1—esophageal cancer	3.08e-06	2.43e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS1—esophageal cancer	3.08e-06	2.43e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ABCB1—esophageal cancer	3.06e-06	2.41e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PSME2—esophageal cancer	3.03e-06	2.39e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PSME1—esophageal cancer	3.03e-06	2.39e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP19A1—esophageal cancer	3.02e-06	2.38e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—HMOX1—esophageal cancer	3.01e-06	2.37e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP26A1—esophageal cancer	3e-06	2.37e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.95e-06	2.33e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MYC—esophageal cancer	2.94e-06	2.32e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.93e-06	2.31e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—EP300—esophageal cancer	2.9e-06	2.28e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ABCB1—esophageal cancer	2.89e-06	2.28e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CREBBP—esophageal cancer	2.83e-06	2.23e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TPI1—esophageal cancer	2.79e-06	2.2e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.79e-06	2.2e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—HMOX1—esophageal cancer	2.76e-06	2.17e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.71e-06	2.13e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.68e-06	2.11e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.65e-06	2.09e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ABCB1—esophageal cancer	2.65e-06	2.09e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—EP300—esophageal cancer	2.63e-06	2.07e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP1B1—esophageal cancer	2.62e-06	2.06e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CREBBP—esophageal cancer	2.59e-06	2.04e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.58e-06	2.03e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.55e-06	2.01e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—NOS3—esophageal cancer	2.53e-06	2e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP19A1—esophageal cancer	2.46e-06	1.94e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CA—esophageal cancer	2.45e-06	1.93e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GNG7—esophageal cancer	2.43e-06	1.92e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—NOS3—esophageal cancer	2.32e-06	1.83e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS2—esophageal cancer	2.31e-06	1.82e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.28e-06	1.8e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HMOX1—esophageal cancer	2.24e-06	1.77e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.2e-06	1.74e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.18e-06	1.72e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTT1—esophageal cancer	2.17e-06	1.71e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ABCB1—esophageal cancer	2.15e-06	1.7e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CA—esophageal cancer	2.14e-06	1.69e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP2A6—esophageal cancer	2.14e-06	1.69e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS2—esophageal cancer	2.12e-06	1.67e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CREBBP—esophageal cancer	2.09e-06	1.65e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CREBBP—esophageal cancer	2.04e-06	1.61e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ENO1—esophageal cancer	2.03e-06	1.6e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS1—esophageal cancer	2.03e-06	1.6e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2e-06	1.58e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PSME1—esophageal cancer	2e-06	1.58e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PSME2—esophageal cancer	2e-06	1.58e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CA—esophageal cancer	1.94e-06	1.53e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CREBBP—esophageal cancer	1.93e-06	1.52e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—EP300—esophageal cancer	1.92e-06	1.52e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—NOS3—esophageal cancer	1.87e-06	1.48e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—NOS3—esophageal cancer	1.83e-06	1.44e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CREBBP—esophageal cancer	1.77e-06	1.4e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—EP300—esophageal cancer	1.76e-06	1.39e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—NOS3—esophageal cancer	1.73e-06	1.36e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.73e-06	1.36e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS2—esophageal cancer	1.71e-06	1.35e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS2—esophageal cancer	1.67e-06	1.32e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.63e-06	1.28e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.62e-06	1.28e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NOS3—esophageal cancer	1.58e-06	1.25e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS2—esophageal cancer	1.58e-06	1.25e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.48e-06	1.17e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS2—esophageal cancer	1.45e-06	1.14e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CREBBP—esophageal cancer	1.44e-06	1.14e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CA—esophageal cancer	1.42e-06	1.12e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—EP300—esophageal cancer	1.42e-06	1.12e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.42e-06	1.12e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—EP300—esophageal cancer	1.39e-06	1.1e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—EP300—esophageal cancer	1.31e-06	1.04e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CA—esophageal cancer	1.31e-06	1.03e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NOS3—esophageal cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—EP300—esophageal cancer	1.21e-06	9.5e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS2—esophageal cancer	1.18e-06	9.3e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CA—esophageal cancer	1.05e-06	8.3e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CA—esophageal cancer	1.03e-06	8.12e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—EP300—esophageal cancer	9.81e-07	7.73e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CA—esophageal cancer	9.72e-07	7.67e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CREBBP—esophageal cancer	9.5e-07	7.49e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CA—esophageal cancer	8.91e-07	7.03e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NOS3—esophageal cancer	8.5e-07	6.71e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS2—esophageal cancer	7.78e-07	6.13e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CA—esophageal cancer	7.26e-07	5.72e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—EP300—esophageal cancer	6.47e-07	5.1e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CA—esophageal cancer	4.78e-07	3.77e-06	CbGpPWpGaD
